Author Archives: Jennifer Walker-Journey

European advisors recommend approval of new combination type 2 diabetes treatment

Posted: July 29, 2014 Pharmaceutical

An advisory panel for European drug regulators is recommending approval for a new type 2 diabetes drug combining the long-acting insulin degludec with Victoza (liraglutide). The favorable recommendation of Novo Nordisk’s drug Xultophy, previously known as IDegLira, was based on

Risperidone side effects send patients to the emergency room

Posted: July 28, 2014 Pharmaceutical

Adverse effects of antipsychotic medications such as Risperdal (risperidone) send more than 20,000 people in the United States to the emergency room each year, prompting the American Psychiatric Association to issue an advisory to clinicians to carefully evaluate patients before

Acetaminophen as effective as placebo in treating lower back pain

Posted: July 28, 2014 Pharmaceutical

The commonly used painkiller acetaminophen, the same drug in over-the-counter Tylenol, doesn’t relieve lower-back pain any better than a placebo, according to a new study published in the journal The Lancet.

FDA approves oxycodone combination drug that resists abuse

Posted: July 27, 2014 Pharmaceutical

A powerful combination opioid painkiller whose euphoric effects can be rendered inactive if the drug is tampered with has been approved by the Food and Drug Administration (FDA). The drug’s formulation aligns with the agency’s commitment to combat the misuse

FDA grants breakthrough designation to new pancreatic cancer treatment

Posted: July 27, 2014 Pharmaceutical

A new pancreatic cancer combination treatment has been granted Breakthrough Therapy Designation by the Food and Drug Administration (FDA), giving new options for patients with metastatic pancreatic cancer.

Teen’s death prompts FDA warning for consumers to avoid pure caffeine powder

Posted: July 26, 2014 Pharmaceutical

Logan Stiner was just days away from his high school graduation when he died after consuming a lethal dose of powdered caffeine. The teen’s death prompted a Food and Drug Administration (FDA) investigation resulting in the agency issuing a warning

McNeil loses appeal on $10 million Children’s Motrin judgment

Posted: July 26, 2014 Pharmaceutical

Johnson & Johnson subsidiary McNeil-PPC failed to convince the Pennsylvania Superior Court to overturn a $10 million verdict alleging the company’s Children’s Motrin caused a girl to develop a life threatening condition that burned her skin and caused her to

National Football League Players Association gets hit with concussion injury lawsuit

Posted: July 25, 2014 Personal Injury

The National Football League Players Association (NFLPA), a union for professional football players in the NFL, and three former presidents of the group, have been hit by a lawsuit from two former football players who claim the defendants conspired to

Pharmacy group wants black box warning added to antibiotic Levaquin

Posted: July 25, 2014 Pharmaceutical

A University of South Carolina pharmacy group is petitioning the Food and Drug Administration (FDA) to put the strongest warning possible on Johnson & Johnson’s antibiotic Levaquin alerting consumers about the potential for cellular damage that could lead to serious diseases.

Mislabeled ibuprofen, seizure drugs recalled

Posted: July 24, 2014 Recalls

American Health Packaging (AHP) is recalling packages of the anti-inflammatory drug ibuprofen and the anti-seizure drug oxcarbazepine because the individual blister packs may be mislabeled and contain the wrong drug. Thus, patients prescribed oxcarbazepine may inadvertently take a dose of